The Latest Breaking News from German Center for Infection Research

Licensed Ebola Vaccine Ervebo Triggered T Cells Against Bundibugyo in 13 of 20 Recipients, but Protection Remains Unproven

A small study found that Ervebo sparked Bundibugyo-reactive T cells in 13 of 20 adults. Here is what it means for the Congo trial and U.S. travelers.

Medical Daily · Oct 15

Tanzanian TB patients have a lower quality of life than people who haven't had the disease

Numerous researchers have documented the quality of life and mental health of specific population groups. Examples include people living with HIV, the elderly, students, men who have sex with men, and pregnant women accessing health services. One review found that people with tuberculosis (TB) have a relatively high prevalence of…

The Conversation · Aug 23, 2022